MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-18-2025
Helius Medical Technologies Retained Earnings 2011-2026 | HSDT
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Helius Medical Technologies
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -160 M | -151 M | -137 M | -119 M | -105 M | -95 M | -66.4 M | -26.3 M | -18.5 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -18.5 M | -160 M | -97.5 M |
Quarterly Retained Earnings Helius Medical Technologies
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -538 M | -185 M | -176 M | -172 M | -168 M | -164 M | -162 M | -160 M | -159 M | -155 M | -154 M | -151 M | -146 M | -145 M | -141 M | -137 M | -133 M | -128 M | -122 M | -119 M | -119 M | -119 M | -119 M | -105 M | -105 M | -105 M | -105 M | -95 M | -95 M | -95 M | -95 M | -66.4 M | -66.4 M | -66.4 M | -66.4 M | -38.3 M | -38.3 M | -38.3 M | -38.3 M | -22.5 M | -20 M | -21.8 M | -19.4 M | - | - | - | -9.59 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -9.59 M | -538 M | -116 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AxoGen
AXGN
|
-307 M | $ 32.5 | -8.14 % | $ 1.44 B |  USA |
 |
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
Alphatec Holdings
ATEC
|
-1.42 B | $ 13.77 | 4.86 % | $ 1.97 B | USA |
 |
Bio-Rad Laboratories
BIO
|
7.42 B | $ 269.87 | 0.53 % | $ 7.61 B | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
Apyx Medical Corporation
APYX
|
-54.4 M | $ 3.53 | -1.12 % | $ 122 M | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
-191 M | $ 14.58 | -1.22 % | $ 394 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
-157 M | $ 6.36 | 0.32 % | $ 457 M |  Israel |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
Bruker Corporation
BRKR
|
2.41 B | $ 39.87 | 0.77 % | $ 5.94 K | USA |
 |
BioSig Technologies
BSGM
|
-255 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
5.57 B | $ 75.27 | 1.21 % | $ 111 B | USA |
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 4.52 | - | $ 169 M |  France |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
21.2 M | $ 23.17 | -5.16 % | $ 196 M | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 46.0 | 1.39 % | $ 1.43 B | USA |
 |
Second Sight Medical Products
EYES
|
-122 M | - | -0.97 % | $ 54.4 M | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | USA |
 |
Cutera
CUTR
|
-303 M | - | -10.19 % | $ 1.99 M | USA |
 |
Delcath Systems
DCTH
|
-532 M | $ 9.94 | 2.0 % | $ 283 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
InMode Ltd.
INMD
|
969 M | $ 14.0 | -1.41 % | $ 905 M | Israel |
 |
Establishment Labs Holdings
ESTA
|
-445 M | $ 78.78 | 5.1 % | $ 2.22 B |  Costa-rica |
 |
IRadimed Corporation
IRMD
|
56.8 M | $ 99.04 | -2.22 % | $ 1.25 B | USA |
 |
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | USA |
 |
FONAR Corporation
FONR
|
-33.6 M | $ 18.55 | -0.22 % | $ 122 M | USA |
 |
Globus Medical
GMED
|
1.39 B | $ 92.25 | -1.25 % | $ 12.5 B | USA |
 |
LivaNova PLC
LIVN
|
-903 M | $ 69.26 | 1.32 % | $ 3.76 B |  Britain |
 |
Pulmonx Corporation
LUNG
|
-468 M | $ 1.51 | 2.03 % | $ 59.1 M | USA |
 |
Medtronic PLC
MDT
|
31.5 B | $ 97.06 | -1.57 % | $ 125 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
940 M | $ 11.57 | -1.66 % | $ 891 M | USA |
 |
MiMedx Group
MDXG
|
-91.3 M | $ 5.35 | 0.28 % | $ 786 M | USA |